Annual total expenses:
$678.01M+$297.51M(+78.19%)Summary
- As of today (September 17, 2025), MDGL annual total expenses is $678.01 million, with the most recent change of +$297.51 million (+78.19%) on December 31, 2024.
- During the last 3 years, MDGL annual total expenses has risen by +$435.53 million (+179.61%).
- MDGL annual total expenses is now at all-time high.
Performance
MDGL Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$255.08M+$44.59M(+21.19%)Summary
- As of today (September 17, 2025), MDGL quarterly total expenses is $255.08 million, with the most recent change of +$44.59 million (+21.19%) on June 30, 2025.
- Over the past year, MDGL quarterly total expenses has increased by +$88.47 million (+53.10%).
- MDGL quarterly total expenses is now at all-time high.
Performance
MDGL Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
MDGL Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.2% | +53.1% |
| 3 y3 years | +179.6% | +260.6% |
| 5 y5 years | +613.9% | +420.3% |
MDGL Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +179.6% | at high | +260.6% |
| 5 y | 5-year | at high | +613.9% | at high | +420.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
MDGL Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $255.08M(+21.2%) |
| Mar 2025 | - | $210.49M(+29.3%) |
| Dec 2024 | $678.01M(+78.2%) | $162.74M(-3.8%) |
| Sep 2024 | - | $169.14M(+1.5%) |
| Jun 2024 | - | $166.61M(+12.9%) |
| Mar 2024 | - | $147.54M(+31.5%) |
| Dec 2023 | $380.50M(+29.6%) | $112.19M(+13.6%) |
| Sep 2023 | - | $98.74M(+15.1%) |
| Jun 2023 | - | $85.80M(+11.6%) |
| Mar 2023 | - | $76.90M(-10.5%) |
| Dec 2022 | $293.57M(+21.1%) | $85.91M(+5.8%) |
| Sep 2022 | - | $81.20M(+14.8%) |
| Jun 2022 | - | $70.73M(+23.0%) |
| Mar 2022 | - | $57.52M(-10.9%) |
| Dec 2021 | $242.48M(+17.3%) | $64.55M(+2.3%) |
| Sep 2021 | - | $63.10M(+2.4%) |
| Jun 2021 | - | $61.65M(+17.3%) |
| Mar 2021 | - | $52.55M(-11.1%) |
| Dec 2020 | $206.67M(+117.6%) | $59.12M(+2.0%) |
| Sep 2020 | - | $57.96M(+18.2%) |
| Jun 2020 | - | $49.02M(+35.7%) |
| Mar 2020 | - | $36.13M(+30.3%) |
| Dec 2019 | $94.97M(+133.4%) | $27.74M(+29.5%) |
| Sep 2019 | - | $21.43M(+8.8%) |
| Jun 2019 | - | $19.70M(+30.6%) |
| Mar 2019 | - | $15.08M(+31.4%) |
| Dec 2018 | $40.68M(+26.9%) | $11.47M(+34.8%) |
| Sep 2018 | - | $8.51M(+31.8%) |
| Jun 2018 | - | $6.46M(+1.5%) |
| Mar 2018 | - | $6.36M(-24.6%) |
| Dec 2017 | $32.06M(+27.1%) | $8.45M(+1.0%) |
| Sep 2017 | - | $8.36M(+0.2%) |
| Jun 2017 | - | $8.35M(+39.1%) |
| Mar 2017 | - | $6.00M(-22.6%) |
| Dec 2016 | $25.22M(+680.2%) | $7.75M(-44.8%) |
| Sep 2016 | - | $14.05M(+388.3%) |
| Jun 2016 | - | $2.88M(+68.0%) |
| Mar 2016 | - | $1.71M(-9.0%) |
| Dec 2015 | $3.23M(-96.1%) | $1.88M(+4.6%) |
| Sep 2015 | - | $1.80M(-90.9%) |
| Jun 2015 | - | $19.80M(-4.4%) |
| Mar 2015 | - | $20.71M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $83.95M(-4.1%) | $20.35M(+1.9%) |
| Sep 2014 | - | $19.97M(-10.4%) |
| Jun 2014 | - | $22.29M(-5.4%) |
| Mar 2014 | - | $23.56M(-2.5%) |
| Dec 2013 | $87.56M(+43.3%) | $24.16M(+7.3%) |
| Sep 2013 | - | $22.52M(-1.2%) |
| Jun 2013 | - | $22.79M(+9.9%) |
| Mar 2013 | - | $20.73M(+14.4%) |
| Dec 2012 | $61.09M(+15.2%) | $18.12M(+20.9%) |
| Sep 2012 | - | $15.00M(+2.6%) |
| Jun 2012 | - | $14.62M(-2.9%) |
| Mar 2012 | - | $15.05M(+6.2%) |
| Dec 2011 | $53.02M(+2.5%) | $14.17M(-1.6%) |
| Sep 2011 | - | $14.40M(+3.9%) |
| Jun 2011 | - | $13.86M(+10.5%) |
| Mar 2011 | - | $12.54M(-2.5%) |
| Dec 2010 | $51.70M(-18.8%) | $12.86M(-5.8%) |
| Sep 2010 | - | $13.64M(+9.7%) |
| Jun 2010 | - | $12.43M(-6.7%) |
| Mar 2010 | - | $13.33M(+13.8%) |
| Dec 2009 | $63.70M(-33.9%) | $11.72M(-4.6%) |
| Sep 2009 | - | $12.29M(-6.5%) |
| Jun 2009 | - | $13.14M(-53.1%) |
| Mar 2009 | - | $28.01M(+5.3%) |
| Dec 2008 | $96.32M(+43.9%) | $26.59M(-3.6%) |
| Sep 2008 | - | $27.59M(+25.1%) |
| Jun 2008 | - | $22.06M(+16.2%) |
| Mar 2008 | - | $18.99M(+16.7%) |
| Dec 2007 | $66.96M(+13.2%) | $16.27M(+9.4%) |
| Sep 2007 | - | $14.88M(-11.1%) |
| Jun 2007 | - | $16.74M(+2.4%) |
| Mar 2007 | - | $16.36M(+31.0%) |
| Dec 2006 | $59.15M(-16.9%) | $12.49M(-10.3%) |
| Sep 2006 | - | $13.93M(-4.9%) |
| Jun 2006 | - | $14.65M(-9.7%) |
| Mar 2006 | - | $16.21M(-12.4%) |
| Dec 2005 | $71.18M(+56.4%) | - |
| Mar 2005 | - | $18.50M(+228.9%) |
| Dec 2004 | $45.52M(+53.8%) | - |
| Mar 2004 | - | $5.63M |
| Dec 2003 | $29.60M(+305.9%) | - |
| Dec 2002 | $7.29M(+1718.5%) | - |
| Dec 2001 | $401.00K | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual total expenses?
- What is the all time high annual total expenses for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly total expenses?
- What is the all time high quarterly total expenses for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of MDGL is $678.01M
What is the all time high annual total expenses for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual total expenses is $678.01M
What is Madrigal Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, MDGL annual total expenses has changed by +$297.51M (+78.19%)
What is Madrigal Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of MDGL is $255.08M
What is the all time high quarterly total expenses for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly total expenses is $255.08M
What is Madrigal Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, MDGL quarterly total expenses has changed by +$88.47M (+53.10%)